DLB - Company ID 0001308547
The table below shows Dolby Laboratories, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | $1.16B |
| Cost of revenue | $160.13M | $140.50M | $152.57M | $141.36M | $130.03M | $146.50M |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B | $1.02B |
| R&D | $261.79M | $263.66M | $271.52M | $261.17M | $253.64M | $239.04M |
Dolby Laboratories, Inc. reported annual revenue of $1.35B for fiscal year 2025. That is up 5.9% from $1.27B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.03B (FY 2016) to $1.35B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $286.53M |
| $270.39M |
| $258.48M |
| $275.31M |
| $224.16M |
| $219.75M |
| Operating income | $264.96M | $258.33M | $215.75M | $206.60M | $344.39M | $218.74M |
| Income tax | $46.99M | $48.16M | $48.41M | $31.38M | $36.69M | $8.10M |
| Net income | $255.02M | $261.82M | $200.66M | $184.09M | $310.23M | $231.36M |
| EPS (diluted) | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 |